Suchergebnisse - "Jing, Xuquan"

PubPharm (21)

1

Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases : a retrospective study

enthalten in: Future oncology (London, England) | 2024

von Lu, S. | Guo, X. | Yang, Z. | +4

2

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases

enthalten in: Journal of neuro-oncology | 2023

von Jia, W. | Zhai, X. | Jing, X. | +5

3

Programmed cell death 1 pathway inhibitors improve the overall survival of small cell lung cancer patients with brain metastases

enthalten in: Journal of cancer research and clinical oncology | 2023

von Chang, J. | Jing, X. | Hua, Y. | +5

4

Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy : a retrospective study from a single cancer center

enthalten in: Discover. Oncology | 2023

von Li, Y. | Jing, W. | Jing, X. | +5

5

Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center

enthalten in: Discover oncology | 2023

von Li, Y. | Jing, W. | Jing, X. | +5

6

Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center

enthalten in: Hormones and cancer | 2023

von Li, Y. | Jing, W. | Jing, X. | +5

7

Consolidative thoracic radiation could not improve survival of extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: results from a single cancer center

enthalten in: ResearchSquare.com | 2023

von Li, Y. | Jing, W. | Jing, X. | +5

8

Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor

enthalten in: Immunotherapy | 2022

von Jing, X. | Zhu, H. | Li, Y. | +4

9

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy

enthalten in: Cancer letters | 2022

von Tian, Y. | Ma, J. | Jing, X. | +5

10

Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC : The ALTER-L042 Phase 1 Clinical Trial

enthalten in: JTO clinical and research reports | 2022

von Zhu, H. | Jia, W. | Jing, X. | +3